M&As this week: Silver Falcon, Adcock Ingram Holdings, Boya Bio-pharmaceutical Group


Financial services provider Silver Falcon plans to acquire biotechnology company Hemogenyx Pharmaceuticals (Hemogenyx Pharma) for £8m ($10.5m).

The transaction will enable the acquirer company to expand its business operations.

Both the acquirer and target companies are based in the UK.

Adcock Ingram Holdings has announced its 100% acquisition of Genop Holdings, a subsidiary of healthcare service provider Genop Healthcare.

The transaction complements the acquirer company’s existing portfolio.

"Adcock Ingram Holdings has announced its 100% acquisition of Genop Holdings, a subsidiary of healthcare service provider Genop Healthcare."

Both companies involved in the acquisition are based in South Africa.

Chinese biopharmaceutical products provider Boya Bio-pharmaceutical Group (formerly Jiangxi Boya Bio-Pharmaceutical), plans to acquire 82% stake in an undisclosed Chinese pharmaceutical company.

Financial services provider China Huarong Asset Management (formerly China Huarong Asset Management), has announced the sale of eight million shares representing 1.73% stake in pharmaceutical company Northeast Pharmaceutical Group.

Both companies involved in the transaction are based in China.